About the author

Max Reiboldt, CPA, is the chief executive officer of Coker. He has dedicated his career to understanding and solving the complexities faced by healthcare providers, health systems, and private equity investors. His hands-on approach and open communication style have made him a trusted advisor and consultant nationwide.

Contents

  • Acknowledgments
  • Introduction to Private Equity and Healthcare
  • Chapter 1: An Overview of Private Equity and Healthcare
  • Defining Private Equity
  • History of Private Equity in the Healthcare Industry
  • Evolution of the System
  • Private Equity Successes and Failures
  • Private Equity and Ancillary Services
  • Financial Ramifications of Private Equity Transactions in Healthcare
  • Private Equity and Investment Return
  • Summary
  • Chapter 2: Typical Private Equity Healthcare Structures
  • Inherent Features of PE and Healthcare Transactions
  • Features of Typical PE Healthcare Transactions — Purchaser
  • PE Operational Entity/Management Organization
  • Purchaser Characteristics
  • Features of Typical PE Healthcare Transactions — Seller
  • Seller Considerations — Exit Windows
  • Healthcare Regulatory Considerations
  • Overall Goals and Objectives
  • Summary
  • Chapter 3: Healthcare Laws Impacting Private Equity Transactions
  • Corporate Practice of Medicine
  • Antitrust Considerations
  • The Anti-Kickback Statute
  • The Physician Self-Referral Law (Stark Law)
  • The False Claims Act
  • Loper Bright Enterprises v. Raimondo
  • Summary
  • Chapter 4: Valuation and Quality of Earnings in Private Equity Transactions
  • Enterprise Value
  • Valuation Processes
  • Overview of QofE
  • Key Benefits
  • QofE Report Example
  • Key Steps
  • Summary
  • Chapter 5: Physician Dynamics in Private Equity Transactions
  • Physician Options Relative to Practice Structure
  • Physicians and Private Equity Opportunities
  • Relevant Matters for Physicians
  • Summary
  • Chapter 6: Economic Pros and Cons in Private Equity Transactions
  • Economic Components
  • Upfront Funds
  • PE Model Valuation
  • Practice Agreements Regarding Valuation and Upfront Dollars
  • Rollover Equity Considerations
  • Multiples of Earnings
  • Post-Transaction Economics
  • Summary
  • Chapter 7: Non-Economic Pros and Cons of Private Equity
  • Economic vs. Non-Economic Considerations
  • Non-Economic Factors
  • Summary
  • Chapter 8: Ancillaries and Private Equity Transactions
  • Structural Examples
  • Ancillary Values
  • Non-Clinical Ancillaries
  • Legal and Regulatory Issues
  • Specific Ancillary Services
  • Ambulatory Surgery Centers
  • Cardiology
  • Orthopedics
  • Other Specialties
  • Summary
  • Chapter 9: The Role of MSOs and BSOs in Private Equity Deals
  • PE Deal Structure and MSOs or BSOs
  • MSO and BSO Structures and Strategies
  • Exit Scenarios
  • Summary
  • Chapter 10: Affiliate Contrasts
  • PE vs. Platform
  • Other Possible Affiliates
  • Summary
  • Chapter 11: Specialty Nuances
  • The Consolidation Curve
  • Hospital- and Contract-Based Specialties
  • Anesthesiology
  • Radiology
  • Emergency Medicine
  • Non-Hospital-Affiliated Specialties
  • Dermatology
  • Ophthalmology
  • Dental
  • Other Specialty Practices
  • Gastroenterology
  • Urology
  • Women’s Health
  • Orthopedics
  • Oncology
  • Cardiology
  • Future Specialties
  • Summary
  • Chapter 12: Conclusions Regarding Private Equity Deals
  • Critical Characteristics of PE-Backed Firms and Healthcare Entity Affiliation
  • Key Similarities
  • Key Differences
  • Economics
  • Structure
  • Governance
  • Recommended Attitude Toward PE — Practice or Healthcare Provider
  • Perspectives
  • Challenges Involving Hospitals
  • Challenges Regarding Group Mergers and PE Deals
  • Summary
  • Chapter 13: The Future of Private Equity in Healthcare
  • Trends and Considerations
  • Summary
  • Appendix A: Examples of Private Equity Firms and Associated Specialties
  • Appendix B: Case Studies
  • Case Study One: Preparing to Consider Private Equity Affiliation
  • Case Study Two: Sell-Side Representation Processes
  • Summary
  • Case Study Three: Sell-Side Negotiations
  • Case Study Four: Sell-Side Transaction Finalization
  • Appendix C: Statutory Resources
  • Corporate Practice of Medicine
  • Antitrust
  • Pre-merger Notification Program
  • Private Equity
  • No Surprises Act
  • Anti-Kickback
  • Appendix D: Glossary of Terms in PE Transactions
  • Appendix E: General Formatting for the QofE Report